Explore more publications!

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on March 5, 2026

Calidi Biotherapeutics Announces Proposed Public Offering
President & CEO Letter to Shareholders
Nova Leap Health Corp. Posts Fourth Quarter and Record Full-Year 2025 Revenues and Adjusted EBITDA
COSCIENS Provides Strategic Update
MediWound Files Annual Report on Form 20-F
MannKind Announces Settlement of Convertible Senior Notes
New Book “Avoiding Toxins” Offers a Physician’s Practical Playbook for Navigating America’s Hidden Environmental Exposure Crisis
Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026
CooperCompanies Announces First Quarter 2026 Results
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care
Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
Regeneron Announces Investor Conference Presentation
Amneal to Participate in Upcoming Investor Conference
Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
NextCure Provides Business Update and Reports Full Year 2025 Financial Results
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress
Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Année 2025 le 19 Mars 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions